BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22425034)

  • 1. Adrenomedullin and pregnancy: perspectives from animal models to humans.
    Lenhart PM; Caron KM
    Trends Endocrinol Metab; 2012 Oct; 23(10):524-32. PubMed ID: 22425034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial expression of components of a calcitonin receptor-like receptor (CRL) signalling system (CRL, calcitonin gene-related peptide, adrenomedullin, adrenomedullin-2/intermedin) in mouse and human heart valves.
    Pfeil U; Bharathala S; Murtaza G; Mermer P; Papadakis T; Boening A; Kummer W
    Cell Tissue Res; 2016 Dec; 366(3):587-599. PubMed ID: 27553639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
    Hay DL; Walker CS; Poyner DR
    Endocr Relat Cancer; 2011 Feb; 18(1):C1-14. PubMed ID: 21051558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP.
    Holmes D; Campbell M; Harbinson M; Bell D
    Curr Protein Pept Sci; 2013 Jun; 14(4):294-329. PubMed ID: 23745696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenomedullin - Current perspective on a peptide hormone with significant therapeutic potential.
    Fischer JP; Els-Heindl S; Beck-Sickinger AG
    Peptides; 2020 Sep; 131():170347. PubMed ID: 32569606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of pronociceptive mediators and downregulation of opioid peptide by adrenomedullin following chronic exposure to morphine in rats.
    Wang D; Li J; Chen P; Hong Y
    Neuroscience; 2014 Nov; 280():31-9. PubMed ID: 25218960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice.
    Li M; Yee D; Magnuson TR; Smithies O; Caron KM
    J Clin Invest; 2006 Oct; 116(10):2653-62. PubMed ID: 16981008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared and separate functions of the RAMP-based adrenomedullin receptors.
    Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
    Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adrenomedullin receptor and calcitonin gene-related peptide receptor antagonists on centrally mediated adrenomedullin renal action.
    Diaz E; Israel A
    Brain Res Bull; 2001 May; 55(1):29-35. PubMed ID: 11427334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for adrenomedullin as a pain-related peptide in the rat.
    Ma W; Chabot JG; Quirion R
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):16027-32. PubMed ID: 17043245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenomedullin - new perspectives of a potent peptide hormone.
    Schönauer R; Els-Heindl S; Beck-Sickinger AG
    J Pept Sci; 2017 Jul; 23(7-8):472-485. PubMed ID: 28150464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenomedullin receptors: molecular identity and function.
    Hay DL; Smith DM
    Peptides; 2001 Nov; 22(11):1753-63. PubMed ID: 11754961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin, calcitonin gene-related peptide and their receptors: evidence for a decreased placental mRNA content in preeclampsia and HELLP syndrome.
    Knerr I; Dachert C; Beinder E; Metzler M; Dötsch J; Repp R; Rascher W
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):47-53. PubMed ID: 11905404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
    Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
    J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the activity of CGRP and Adrenomedullin regulated by RAMP (-2) and (-3) in Trypanosomatidae? An in-silico approach.
    Febres A; Vanegas O; Giammarresi M; Gomes C; Díaz E; Ponte-Sucre A
    Infect Genet Evol; 2018 Jul; 61():197-206. PubMed ID: 29626675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenomedullin signaling is necessary for murine lymphatic vascular development.
    Fritz-Six KL; Dunworth WP; Li M; Caron KM
    J Clin Invest; 2008 Jan; 118(1):40-50. PubMed ID: 18097475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily.
    Wimalawansa SJ
    Crit Rev Neurobiol; 1997; 11(2-3):167-239. PubMed ID: 9209829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin: A potential therapeutic target for retinochoroidal disease.
    Iesato Y; Yuda K; Chong KT; Tan X; Murata T; Shindo T; Yanagi Y
    Prog Retin Eye Res; 2016 May; 52():112-29. PubMed ID: 26791747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.